Program Overview |
|
|---|---|
| VA’s ADAP program offers Trofile tropism testing services to uninsured ADAP clients that meet the exception criteria for Trofile testing, and are being considered for use of the CCR5 entry inhibitor drug maraviroc (Selzentry). Maraviroc is a treatment option for experienced clients experiencing virological failure. The Trofile tropism assay determines if the client’s HIV-1 virus uses the CCR5 receptor to enter the CD4 cell. ADAP clients with Medicare, Medicaid, or private insurance must use that coverage to obtain a Trofile test. | |
| VA ADAP has established Trofile assay sample collection sites in two health districts, see Program Structure and Process section below for list of sample collection sites. Expansion plans include the addition of several independent laboratory collection sites as well as several local health district sites. As additional sites are added to the program, VDH will post that information on the VDH ADAP Trofile website. | |
Structure & Process |
|
|---|---|
|
|
|
|
|
|
|
|
Educational Materials |
||
Additional Resource |
||
Questions or comments?
Contact HIV/STD/Viral Hepatitis Hotline